Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer—status of the art
- 29 March 1999
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 30 (1), 71-79
- https://doi.org/10.1016/s1040-8428(98)00036-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- A Simple Chromatographic Method for the Analysis of Pyrimidines and their Dihydrogenated MetabolitesJournal of Liquid Chromatography & Related Technologies, 1997
- Depressed hepatic dihydropyrimidine dehydrogenase activity and fluorouracil-related toxicitiesAmerican Journal Of Medicine, 1995
- Automated screening system for purine and pyrimidine metabolism disorders using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Cisplatin, Fluorouracil, and Leucovorin: Increased Toxicity Without Improved Response in Squamous Cell Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Metabolism and mechanism of action of 5-fluorouracilPharmacology & Therapeutics, 1990
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.JCI Insight, 1988
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil ToxicityNew England Journal of Medicine, 1985
- Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiencyClinica Chimica Acta; International Journal of Clinical Chemistry, 1984